Abstract:Gene therapeutics is a rapidly developing field promising critical advances in finding new vaccines and treatments, as well as genetic adjustments to plants and animal species. This novel area of science may generate treatment pathways for complex diseases such as cancer, Alzheimer's or sickle cell anemia that can not be easily treated by conventional therapies. Recently developed CRISPR technology can help address these issues, having a power to perform treatment targeted to specific disease mechanisms with little to no adverse effects to the healthy tissue. Many gene therapies require intracellular delivery, and their efficacy can be highly influenced by the choice of the delivery vehicle. Due to their near-infrared fluorescence capabilities and large payload carrying capacity, carbon nanomaterials can be appropriate candidates for this role. Our work utilizes graphene quantum dots (GQDs) and single-walled carbon nanotubes (SWCNTs) as delivery vehicles for several CRISPR-Cas9-based formulations specifically designed to edit out genes related to immortalization and uncontrolled growth of cancer cells. Both of these nanomaterials exhibit visible and near-infrared fluorescence capabilities sufficient for in vitro and in vivo imaging, and, when bound to CRISPR-Cas9 system, are not only expected to transport the therapeutic, but also trace its delivery pathways. In order to warrant more efficient complexation with CRISPR-Cas9 system, GQDs are synthesized bottom-up from cationic polymers and characterized to exhibit stable fluorescence and high biocompatibility at ~1 mg/mL in vitro. Payload attachment is assessed microscopically and reflected by Zeta potential variation upon complexation. Both resulting nanomaterials-delivered formulations show successful target gene scission and intracellular tracking of the gene therapeutic via intrinsic nanomaterial fluorescence. The end goal of this work is to edit out and/or correct aberrant genes in cancer cells making them more susceptible to conventional treatment pathways, thus, ultimately helping improve cancer survival rates.

Graphene Quantum Dots for siRNA Delivery in Gene Silencing Cancer Therapy

Graphene Quantum Dots from Natural Carbon Sources for Drug and Gene Delivery in Cancer Treatment

Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells

(Invited) CRISPR-Cas9-Based Cancer Therapy Delivery By Carbon Nanomaterials

The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging.

Fluorescent Carbon Dots As an Efficient Sirna Nanocarrier for Its Interference Therapy in Gastric Cancer Cells.

GFP Plasmid and Chemoreagent Conjugated with Graphene Quantum Dots as a Novel Gene Delivery Platform for Colon Cancer Inhibition In Vitro and In Vivo

SiRNA Delivery with PEGylated Graphene Oxide Nan Osheets for Combined Photothermal and Genetherapy for Pancreatic Cancer

High Transfection Efficiency of Quantum Dot-Antisense Oligonucleotide Nanoparticles in Cancer Cells Through Dual-Receptor Synergistic Targeting

Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy

A Novel Graphene Quantum Dot-Based mRNA Delivery Platform.

Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy

Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles

Graphene Quantum Dots for Radiotherapy

Lipid nanoparticles as nano-Trojan-horses for siRNA delivery and gene-knockdown

Carbon Dots with Guanidinium and Amino Acid Functional Groups for Targeted Small Interfering RNA Delivery toward Tumor Gene Therapy.

Tumor-Targeted In Vivo Gene Silencing Via Systemic Delivery Of Crgd-Conjugated Sirna

Graphene quantum dot formulation for cancer imaging and redox-based drug delivery

Automated Approach to In Vitro Image-Guided Photothermal Therapy with Top-Down and Bottom-Up-Synthesized Graphene Quantum Dots

Efficient nanocarriers of siRNA therapeutics for cancer treatment

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery